Skp2–MacroH2A1–CDK8 axis orchestrates G2/M transition and tumorigenesis
2015 · Nature Communications · 120 citations
https://doi.org/10.1038/ncomms7641
X
Xiao‐Feng Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
174
Papers
6.7K
Citations
41
h-index
116
i10-index
Xiao‐Feng Zhu is an academic researcher from Shenyang Agricultural University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & Autophagy in Disease and Therapy. The author has an h-index of 41, co-authored 148 publications.
ORCID: 0000-0002-1313-4783Papers by this author
worksHigher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
2009 · Journal of Translational Medicine · 101 citations
https://doi.org/10.1186/1479-5876-7-56
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells
2010 · Medical Oncology · 51 citations
https://doi.org/10.1007/s12032-010-9630-0
Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression
2022 · Nature Communications · 47 citations
https://doi.org/10.1038/s41467-022-31417-x
ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway
2009 · Journal of Translational Medicine · 35 citations
https://doi.org/10.1186/1479-5876-7-74
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
2022 · Journal for ImmunoTherapy of Cancer · 35 citations
https://doi.org/10.1136/jitc-2021-004338
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat